QUEENS UNIVERSITY BELFAST

Research Fellow, Ocular Drug Delivery

Location
Belfast, Northern Ireland
Salary
£33,797 - £36,914 per annum
Posted
Sunday, 16 February 2020
End of advertisement period
Wednesday, 19 February 2020
Ref
20/108111
Contract Type
Permanent
Hours
Full Time

Application closing date 19/02/2020  
Salary £33,797 - £36,914 per annum  
Job category/type Research
Attachments      

Job description

We are recruiting for a Research Fellow to join the Ocular Drug Delivery research group led by Dr Raj Thakur in the School of Pharmacy at Queen's University Belfast. The successful candidate will develop and plan research in novel controlled release drug delivery systems for ocular application on an industry funded research project.  

The Research Fellow will design, develop and refine experimental apparatus and experiments for the preparation, characterisation and development of controlled release drug delivery systems.   Responsibilities will also include development and validation of analytical/bio-analytical techniques; conducting stability studies for small and large molecules.  

The successful Research Fellow must have: 

  • 2:1 Honors Degree or equivalent in pharmacy, polymer science, or pharmaceutical chemistry 
  • Have or about to obtain a PhD in pharmacy, drug delivery, or pharmaceutics.
  • At least 3 years recent and relevant research experience in the area of Ocular drug delivery.
  • Experience in laboratory-based research in fabrication and characterization of long-acting depot forming formulations
  • Experience in biocompatibility studies of ocular implants 
  • Experience in analytical method development and validation of biologics (e.g. HPLC, ELISA, SEC-HPLC)

The School of Pharmacy at Queen's is acknowledged as a leading centre for Pharmacy teaching and research in the UK.  At Queen's we believe in providing students with as authentic a learning experience and environment as possible. We have world leading research laboratories with the best technology in the industry.  In the latest rankings in the Times and Sunday Times Good University Guide 2020 the School has been ranked 1st in Pharmacy and Pharmacology Research and 2nd for Pharmacology and Pharmacy.  

Queen's is a driver of innovation based on our talented, multinational workforce.Throughout the University, our academics are collaborating across disciplines to develop new discoveries and insights, working with outside agencies and institutions on projects of international significance. We are connected and networked with strategic partnerships across the world, helping us to expand our impact on wider society locally, nationally and globally. The University is committed to attracting, retaining and developing the best global talent within an environment that enables them to realise their full potential.

We are a leader in gender equality and diversity, and are one of the UK's most successful universities in the Athena SWAN initiative which promotes gender equality and career progression. The School of Pharmacy holds an Athena SWAN Silver award in recognition of our commitment and success in addressing gender equality, representation, progression and success for all our staff.  We are ranked 1st in the UK for Knowledge Transfer Partnerships, (Innovate UK) 9th in the UK for University facilities (Times Higher Education Student Experience Survey 2018) and 14th in the UK for research quality (Times and Sunday Times Good University Guide 2019).

Our five core values - Integrity, Connected, Ambition, Respect, Excellence - are shared by our staff and students, representing the expectations we have for ourselves and each other, guiding our day-to-day decisions and the way we behave as individuals in an international organisation. 

Informal enquiries may be directed to Dr Shirish Yakkundi via email to s.yakkundi@qub.ac.uk

This post is available for 31 January 2021.

Salary:  GBP 33,797 - GBP 36,914 per annum

Candidate Information 
About the School 
About the Group Leader
Further Information for International ApplicantsNote to EEA Applicants on Brexit